Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2025

Overview

Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2025 is an advanced educational program designed to provide comprehensive updates in the rapidly evolving fields of gastrointestinal, hepatic, biliary, and pancreatic pathology. Led by distinguished Harvard faculty and internationally recognized experts, the course delivers practical, case-based learning focused on the diagnostic challenges encountered in everyday pathology practice.

This intensive program explores the latest developments in digestive system pathology, including updates to the WHO Classification of Tumors of the Digestive System, emerging disease entities, advances in molecular diagnostics, biomarker testing, and modern approaches to disease staging and grading. Participants will learn how to integrate histologic findings with immunohistochemical, molecular, and clinical data to improve diagnostic accuracy and patient management.

A major focus of the course is the interpretation of challenging gastrointestinal, liver, and pancreatic specimens. Through expert lectures, interactive discussions, and slide-based seminars, attendees will review current diagnostic criteria, differential diagnoses, reporting standards, and prognostic markers relevant to both neoplastic and non-neoplastic disorders.

Key Topics Covered

Upper Gastrointestinal Pathology

• Barrett’s esophagus and associated neoplasia
• Upper GI inflammatory disorders
• Gastric polyps and precursor lesions
• Celiac disease and differential diagnosis
• Clinical-pathologic correlation in upper GI disease

Lower Gastrointestinal Pathology

• Biopsy diagnosis of colitis
• Inflammatory bowel disease (IBD)
• Colon polyps and hereditary polyposis syndromes
• Colorectal cancer pathology and staging
• Challenging lower GI pathology cases

Pancreatic Pathology

• Surgical pathology of pancreatic tumors
• Cytology and small biopsy diagnosis of pancreatic neoplasms
• Benign and malignant pancreatic disorders
• Prognostic markers and reporting standards
• Case-based pancreatic pathology seminars

Gastrointestinal Tumors & Molecular Diagnostics

• Gastrointestinal stromal tumors (GIST)
• Mesenchymal tumors and polyps
• Gastrointestinal lymphomas
• Appendiceal neoplasms
• Neuroendocrine tumors of the gastrointestinal tract
• Molecular diagnostics in GI malignancies
• Biomarker testing and targeted therapies

Liver & Biliary Pathology

• Approach to chronic hepatitis
• Drug-induced liver injury
• Primary hepatic neoplasms
• Granulomatous liver diseases
• Liver biopsy interpretation
• Gallbladder and biliary tract pathology
• Challenging hepatic pathology cases

Learning Objectives

Upon completion of this course, participants will be able to:

• Discuss recent updates in the WHO classification of digestive system tumors.
• Identify newly recognized entities in gastrointestinal inflammatory disease pathology.
• Apply immunohistochemical and molecular techniques in the diagnosis of pre-neoplastic and neoplastic lesions.
• Utilize current biomarker testing strategies for hereditary cancer syndromes and targeted therapies.
• Interpret complex liver biopsy findings and correlate them with clinical data.
• Apply modern staging and grading systems appropriately in pathology reporting.
• Recognize common and uncommon hepatic neoplasms and their diagnostic features.
• Evaluate pancreatic biopsy specimens and integrate morphologic findings with clinical information.
• Differentiate benign, premalignant, and malignant pancreatic disorders using current diagnostic criteria.

Educational Benefits

Participants will gain practical knowledge from leading experts in gastrointestinal, liver, and pancreatic pathology while reviewing real-world cases and current diagnostic challenges. The program provides valuable updates on disease classification, molecular pathology, cancer biomarkers, and modern diagnostic approaches, helping clinicians and pathologists improve diagnostic confidence, reporting accuracy, and patient care outcomes.